Target type: molecularfunction
Enables the transfer of galactose from one side of a membrane to the other. D-galactose is widely distributed in combined form in plants, animals and microorganisms as a constituent of oligo- and polysaccharides; it also occurs in galactolipids and as its glucoside in lactose and melibiose. [GOC:ai, GOC:mtg_transport, ISBN:0815340729, RHEA:34915]
Galactose transmembrane transporter activity is a molecular function that describes the movement of galactose across cell membranes. This process is essential for the uptake and utilization of galactose, a simple sugar found in various dietary sources like milk and dairy products. Galactose transmembrane transporters are integral membrane proteins that facilitate the passive or active transport of galactose down or against its concentration gradient, respectively. These transporters typically exhibit high specificity for galactose, ensuring its efficient transport while minimizing the movement of other sugars. The mechanism of transport can involve facilitated diffusion, where the transporter simply facilitates the movement of galactose down its concentration gradient, or active transport, which requires energy to move galactose against its concentration gradient. This energy can be derived from ATP hydrolysis or by coupling the transport of galactose to the movement of another molecule down its concentration gradient. The activity of galactose transmembrane transporters is essential for various physiological processes, including the absorption of galactose from the gut, the delivery of galactose to the liver for metabolism, and the utilization of galactose by various tissues. Defects in galactose transmembrane transporter activity can lead to impaired galactose metabolism, resulting in pathological conditions such as galactosemia.'
"
Protein | Definition | Taxonomy |
---|---|---|
Sodium/glucose cotransporter 1 | A sodium/glucose cotransporter 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P13866] | Homo sapiens (human) |
Solute carrier family 2, facilitated glucose transporter member 3 | A solute carrier family 2, facilitated glucose transporter member 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P11169] | Homo sapiens (human) |
Solute carrier family 2, facilitated glucose transporter member 2 | A solute carrier family 2, facilitated glucose transporter member 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P11168] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
phloretin | dihydrochalcones | antineoplastic agent; plant metabolite | |
phlorhizin | aryl beta-D-glucoside; dihydrochalcones; monosaccharide derivative | antioxidant; plant metabolite | |
vexibinol | sophoraflavanone G : A tetrahydroxyflavanone having a structure of naringenin bearing an additional hydroxyl substituent at position 2' as well as a (2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl (lavandulyl) substituent at position 8'. vexibinol: flavanol from Sophora; structure in first source; RN given refers to (S-(R*,S*))-isomer | (2S)-flavan-4-one; 4'-hydroxyflavanones; tetrahydroxyflavanone | antimalarial; antimicrobial agent; antioxidant; plant metabolite |
2',4',6'-Trihydroxydihydrochalcone | chalcones | ||
quercetin | 7-hydroxyflavonol; pentahydroxyflavone | antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger | |
myricetin | 7-hydroxyflavonol; hexahydroxyflavone | antineoplastic agent; antioxidant; cyclooxygenase 1 inhibitor; food component; geroprotector; hypoglycemic agent; plant metabolite | |
cytochalasin b | cytochalasin B : An organic heterotricyclic compound, that is a mycotoxin which is cell permeable an an inhibitor of cytoplasmic division by blocking the formation of contractile microfilaments. Cytochalasin B: A cytotoxic member of the CYTOCHALASINS. | cytochalasin; lactam; lactone; organic heterotricyclic compound | actin polymerisation inhibitor; metabolite; mycotoxin; platelet aggregation inhibitor |
2',4',6'-trihydroxychalcone | pinocembrin chalcone : A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 2', 4' and 6' respectively. pinocembrin chalcone: isolated from Helichrysum trilineatum; structure in first source | chalcones | antifungal agent; plant metabolite |
sergliflozin etabonate | sergliflozin: a hypoglycemic agent that inhibits SGLT2 sodium-glucose transporter; structure in first source | glycoside | |
remogliflozin etabonate | remogliflozin etabonate: orally administered hypoglycemic agent; structure in first source | glycoside | |
dapagliflozin | aromatic ether; C-glycosyl compound; monochlorobenzenes | hypoglycemic agent; sodium-glucose transport protein subtype 2 inhibitor | |
ipragliflozin | glycoside | ||
empagliflozin | aromatic ether; C-glycosyl compound; monochlorobenzenes; tetrahydrofuryl ether | hypoglycemic agent; sodium-glucose transport protein subtype 2 inhibitor | |
1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitol | diarylmethane | ||
nothofagin | nothofagin: a dihydrochalcone | ||
canagliflozin | canagliflozin hydrate : A hydrate that is the hemihydrate form of canagliflozin. Used for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2. | C-glycosyl compound; organofluorine compound; thiophenes | hypoglycemic agent; sodium-glucose transport protein subtype 2 inhibitor |
pf 04971729 | ertugliflozin: structure in first source | diarylmethane | |
deberza | 2-benzofurans |